These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 25155379)

  • 1. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
    Massie AB; Luo X; Alejo JL; Poon AK; Cameron AM; Segev DL
    Liver Transpl; 2015 May; 21(5):683-9. PubMed ID: 25762287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of pretransplant hepatic encephalopathy on survival following liver transplantation.
    Wong RJ; Aguilar M; Gish RG; Cheung R; Ahmed A
    Liver Transpl; 2015 Jul; 21(7):873-80. PubMed ID: 25902933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MELD exceptions and new predictive score of death on long waiting lists for liver transplantation.
    Iacob S; Gheorghe L; Iacob R; Gheorghe C; Hrehoreţ D; Popescu I
    Chirurgia (Bucur); 2009; 104(3):267-73. PubMed ID: 19601457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum sodium and survival benefit of liver transplantation.
    Sharma P; Schaubel DE; Goodrich NP; Merion RM
    Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
    Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
    Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
    Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN
    Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hypoalbuminemia predicts late mortality on the liver transplant waiting list.
    Porrett PM; Baranov E; ter Horst M
    Transplantation; 2015 Jan; 99(1):158-63. PubMed ID: 25050469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for end-stage liver disease-sodium and survival benefit in liver transplantation.
    Vitale A; Bertacco A; Gambato M; D'Amico F; Morales RR; Frigo AC; Zanus G; Burra P; Angeli P; Cillo U
    Transpl Int; 2013 Feb; 26(2):138-44. PubMed ID: 23194386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wait-list mortality of young patients with Biliary atresia: Competing risk analysis of a eurotransplant registry-based cohort.
    van der Doef HPJ; van Rheenen PF; van Rosmalen M; Rogiers X; Verkade HJ;
    Liver Transpl; 2018 Jun; 24(6):810-819. PubMed ID: 29377411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.